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Abstract: The ability to create three-dimensional (3D) models of brain tissue from patient-derived
cells, would open new possibilities in studying the neuropathology of disorders such as epilepsy
and schizophrenia. While organoid culture has provided impressive examples of patient-specific
models, the generation of organised 3D structures remains a challenge. 3D bioprinting is a rapidly
developing technology where living cells, encapsulated in suitable bioink matrices, are printed to
form 3D structures. 3D bioprinting may provide the capability to organise neuronal populations
in 3D, through layer-by-layer deposition, and thereby recapitulate the complexity of neural tissue.
However, printing neuron cells raises particular challenges since the biomaterial environment must be
of appropriate softness to allow for the neurite extension, properties which are anathema to building
self-supporting 3D structures. Here, we review the topic of 3D bioprinting of neurons, including
critical discussions of hardware and bio-ink formulation requirements.
Keywords: three-dimensional (3D) models; bioprinting; 3D printing; patient specific disease
modelling; brain; neural network; 3D scaffolds; organoids; bioink
1. Introduction: The Clinical Need for In Vitro Neural Models
Neurological disorders, such as schizophrenia, bipolar disorder, Parkinson’s disease, Alzheimer’s
disease and epilepsy, affect nearly one in six people on the planet [1]. Often the cause and progression
of these conditions is not well understood, and our understanding is hampered by limitations in the
traditional techniques for studying the brain in situ. While the advent of functional magnetic resonance
imaging (fMRI) has given neuroscientists the capability to non-invasively monitor brain activity in real
time, fMRI is still a low-resolution technique, detecting relative hotspots of brain activity with accuracy
on the scale of millimetres [2,3]. Additionally while higher resolution measurements of brain activity
can be achieved through insertion of penetrating electrodes in animal models [4], animal models have
a limited ability to recapitulate human pathologies, and treatments in animal experiments often do
not concord with human clinical trials [5]. To better understand neurological disorders, and to screen
potential treatments, new strategies are required.
New technologies are now emerging which enable a new way to study the brain—using miniature,
‘brain-like’ systems of neurons grown in the lab [6]. Using this “brain-on-the-bench” approach
researchers can study how neurons communicate and self-organise, without having to invasively probe
a living animal, or person. The development and use of human cell-based 3D models is anticipated
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to provide valuable insight into the pathophysiology of neurological disorders such as epilepsy.
In particular, three-dimensional (3D) cellular and tissue models will hopefully shed new light on the
cause and progress of such diseases, towards developing new and more effective therapies.
In an example of a ‘bottom-up’ approach, neural organoids can be generated from self-organising
stem cell populations. The organoid strategy has received considerable attention; although limitations
in terms of structural organisation, and reproducibility, are recognised. The complementary technology
for ‘top-down’ biofabrication of 3D neural structures is a new frontier, which may be able to address
some of the limitations of organoid strategies. However, the goal of 3D bioprinting neurons brings its
own challenges, namely that of developing bio-ink formulations, which are simultaneously ‘printable’
and permissive to neural differentiation and neurite outgrowth.
Here, we review the topic of 3D bioprinting of neurons, with a focus on epilepsy modelling as
an example application. In particular, we aim to provide critical discussions of several important
questions including: Why 3D? Why 3D bioprinting? What material properties are required to achieve
3D neural networks? What are the hardware and biomaterial constraints for 3D bioprinting, and
how do these conflict with requirements for 3D neuronal culture? What is the state of the art for 3D
bioprinting neurons?
1.1. Epilepsy
Epilepsy is the fourth most prevalent neurological condition worldwide and is a debilitating
and poorly understood disorder. Epileptic disorders present as uncontrollable seizures which can be
dangerous to the patient. Patients may have congenital epilepsy, or it may develop throughout life [7,8].
There are a variety of epileptiform disorders with differing causes such as genetic predisposition, brain
injury, stroke or tumours. However, epilepsy is idiopathic in one third of patients [7–10].
Treatment can involve dietary changes, surgical intervention or antiepileptic drugs (AEDs). AEDs
can be used as monotherapies or in combination with other treatments including other AEDs [7,9,10].
Health care providers prescribe AEDs based on AEDs they have had success with in other patients,
however this is an inefficient approach typically based on trial and error [11]. After cycling through
various monotherapies, combinations of AEDs are tried with some patients taking several different
AEDs at once. AEDs can have debilitating side effects and it can take a long time to find effective
treatment, if at all. Indeed, approximately one third of patients are resistant to treatment with AEDs.
1.1.1. Limitations of Animal Models for Epilepsy
Electrode imaging in vivo only provides limited information about the brain activity of the patient;
and current animal models of epilepsy have their shortcomings [11,12]. For example, one of the
most widely used models of acquired temporal lobe epilepsy (TLE) is the kindling model, where
electrodes with short bursts of electrical activity are applied repetitively to the limbic brain regions,
often the amygdala or hippocampus, of an animal [12]. The resulting seizures, the symptoms, are very
similar to those seen in clinical settings in human patients with TLE. However, the neuropathological
manifestations between the human and the animal model have marked discrepancies. In humans,
TLE appears as hippocampal sclerosis with damage to the amygdala; whereas kindled rats exhibit no
hippocampal damage even after 300 electrical stimulations [12]. This suggests that animal models can
be misleading if symptomatically they appear to mimic human disease, yet the symptoms arise from a
different pathological source. Therefore, more patient specific modelling is desirable as AEDs could be
tested on the patient specific neural tissue to directly observe their effect on neuron activity.
1.1.2. Limitations of In Situ Methods
Electrophysiological recording of brain activity in vivo is an invasive method that is limited by
feasible electrode placement and health of experimental subjects [13]. A non-invasive method of
studying brain function is functional magnetic resonance imaging (fMRI). The fMRI method exploits
the differences in magnetic susceptibility of oxygenated and deoxygenated hemoglobin to create an
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index of brain activity termed blood oxygenation level-dependent (BOLD) contrast MRI [14]. While
the link between neuronal populations and cerebral hemodynamics have been established, the nature
of this link is a matter of contention, and meanwhile there is dispute over the reproducibility of
recordings and interpretation of the data [14]. The most common interpretation is that increases in
the BOLD signal correspond to increases in neural metabolism. Additionally, BOLD signals have
considerable noise from normal physiological processes such as breathing and cardiac function. BOLD
signals are affected by many extrinsic factors such as amount of sleep, diet, and exercise which can
confound results [14]. Additionally, the highest resolution of fMRI is 300 µm meaning that the effects of
pharmacological treatment cannot be explored at the cellular level using fMRI [15]. fMRI is a valuable
tool that could be used in the future in conjunction with neural in vitro models to elucidate the effects
of pharmacological interventions at both a cellular level and whole organ level.
1.2. Personalised Disease Modelling
1.2.1. The Advent of Induced Pluripotency Stem Cells
While harvesting a patient’s neurons to create a “disease-in-a-dish” model would be invasive and
unethical, recent biotechnological developments have introduced the possibility of creating patient
specific disease modelling using stem cells. In 2006 Yamanaka and Takahashi pioneered a method
using retroviral vectors that could reprogram terminally differentiated mature murine fibroblasts to
become pluripotent stem cells. Induced pluripotent stem cells (iPSCs) can differentiate into any cell
type and can be generated by the introduction of four transcription factors, Oct4, Sox2, Nanog, and
Lin28, into a target somatic cell. A major advantage of this technique is that the iPSCs are genetically
identical to the donor cell [16]. Therefore, tissue constructs grown from iPSCs will not be rejected by
the donor’s immune system upon transplantation; and can be used to create genetically specific patient
disease models [17–19]. Barsby et al. (2018) generated functional excitatory and inhibitory neurons
from iPSCs [17].
Ma et al. (2004) demonstrated that stem cells grown in collagen gels with neural differentiation
media, mimic the differentiation of central nervous system (CNS) development in vivo [20]. Via iPSC
technology, patient specific disease models can be grown with the patient’s own genetic material.
Subsequent epileptogenesis and screening of the tissue model with various AEDs can bypass the
existing prolonged AED selection process; and possibly indicate optimal drug dose concentrations,
minimizing side effects [21]. As a clinical tool personalized disease modelling of neural disorders
will improve patient outcomes by facilitating appropriate AED selection on an individualized basis,
accelerating the process of finding an AED regimen that results in the patient being seizure free and
improving patient quality of life. If clinicians had access to a specific model of a patient’s epileptic
brain tissue, they may be able to rapidly ascertain the efficacy of AEDs for that patient [21,22].
1.2.2. Organoid Models
Organoids are simplified organs on a miniature scale (Figure 1A). Brain tissue organoids have
been generated by culturing stem cells in culture conditions and differentiation media that drive the
stem cells to differentiate into precursor cells that in vivo would eventually become a specific brain
region. Current progress in brain organoid technology and its potential impact has been reviewed
elsewhere [6,23–26]. Here, we will limit our discussion to a description of some of the main advantages
and limitations of the organoid approach.
In a seminal 2013 paper, Lancaster et al. demonstrated many of these advantages including:
Generation of cerebral organoids displaying discrete brain regions (Figure 1B); recapitulation of dorsal
cortical organization; recapitulation of human cortical organization; as well as formation of functional
cerebral cortical neurons [27]. In a major advance, the authors also demonstrated that organoids
derived from a human microcephaly patient recapitulated features of the pathology. This pioneering
work has been extended by many other laboratories in recent years.
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For example, Jo et al. (2016) developed organoids consisting of distinct layers of neuronal cells
expressing characteristic markers of human midbrain. Electrophysiological recordings demonstrated
the presence of functional neurons in approximately 20% of the population; and dopamine production
in 3D midbrain-like organoids (MLOs) [28]. Neuromelanin-like granules were detected in MLOs
that were similar in structure to those isolated from human substantia nigra tissues. Quadrato et al.
(2017) performed gene analysis in >80,000 cells from human brain organoids cultured in Matrigel over
nine months, finding cells belonging to various endogenous classes including retinal and cerebral
cortical cells [29]. Dendrite extension and the development of dendritic spines was observed in mature
organoids and the spontaneously-active neuronal networks were confirmed by electrophysiological
analysis [29]. Bagley et al. (2017) developed the fusion method where both dorsal and ventral forebrain
regions were fused into one organoid body with a dorsal-ventral axis [30]. In addition to microcephaly,
disease pathogenesis models have been developed for autism spectrum disorder, Sandhoff disease,
Miller-Dieker syndrome, and schizophrenia [27,31–37]. Brain organoids have also been developed for
Dengue and ZIKA viral infection [34,38,39]. While these studies illustrate the utility of organoids as
neurodevelopmental disease models, they typically only illustrate the effects of chromosomal deletion
on neurodevelopment without showing how the functional activity of neuron firing is affected.
Some disease models derived from iPSCs have been developed for conditions which exhibit
epileptiform activity (e.g., Rhett syndrome, Miller-Dieker syndrome), [35,40] to date no organoid model
has yet been developed specifically for epilepsy; and the differences between the firing patterns of
normal versus epileptic organoids is yet to be explored.
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Organoids possess many of the limitations inherent to other in vitro neural models, in that they 
do not mimic the 3D shape of the human embryonic brain. In vivo, the embryonic brain 
development is guided by the embryonic body axes which are lacking in vitro. Consistent spatial 
development has been achieved in organoids, however a large variability in size and tissue structure 
has limited the generation of disease pathogenesis models [23–25,31]. Organoids are restricted to a 
small size (maximum of several millimeters), due to the lack of nutritional supply to deeper regions 
[23,24,31,41]. Although agitation of the culture promotes the self-organization of neurons, a 
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Organoids possess many of the limitations inherent to other in vitro neural models, in that they
do not mimic the 3D shape of the human embryonic brain. In vivo, the embryonic brain development
is guided by the embryonic body axes which are lacking in vitro. Consistent spatial development
has been achieved in organoids, however a large variability in size and tissue structure has limited
the generation of disease pathogenesis models [23–25,31]. Organoids are restricted to a small size
(maximum of several millimeters), due to the lack of nutritional supply to deeper regions [23,24,31,41].
Although agitation of the culture promotes the self-organization of neurons, a circulatory system would
be necessary to allow metabolite exchange and growth factor diffusion for the organoid to develop the
cortical plate and late-developing neuronal structures [30,38].
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2. In Vitro Neural Models
2.1. 2D versus 3D Neural Culture
2D neuronal cultures have been the standard method for studying neuronal activity in vitro for
several decades. The relative simplicity and versatility of the 2D set-up has allowed for many probing
experiments to gain insight into the influence of substrate mechanics [42,43] or nanotopography
on neuron phenotype [44]. Personalised disease models have also been developed in 2D cultures.
For example, a 2D model of a childhood form of epilepsy PCDH19-Girls Clustering Epilepsy was
developed by Homan et al. (2018). They generated disease model neural stem cells (NSCs) with
dysfunctional PCDH19, which resulted in asynchronous neurogenesis and the loss of apical-basal
polarity in disease model cells [45]. The differential timing of neuron maturation may partially contribute
to network dysfunction and epileptogenesis. Patient specific disease models of Dravet syndrome, a form
of infantile epilepsy, have been developed from neurons derived from iPSCs [19,46,47]. The neurons in
these patient specific models displayed enlarged and persistent sodium channel activation leading
to hallmark epileptic neuron electrophysical activity such as hyperexcitability, increased firing, and
more intensive evoked action potentials compared to healthy patient controls [48]. Lui et al. (2013)
found that the electrophysiological behaviour of the Dravet syndrome patient derived neurons, was
comparable to healthy control neurons after treatment with phenytoin, a common antiepileptic drug
that acts by blocking the activation of voltage gated sodium ion channels.
However, it is becoming increasingly recognised that 2D in vitro models are limited in their ability
to model live tissue [49]. The brain is not a monolayer of cells; although much information can be
gained from studying how neurons interact with each other in planar cultures, it is integral to include
interactions occurring in 3D to recapitulate brain function.
As described in a seminal review by Baker et al. (2012) two-dimensional, monolayer culture
presents an environment that is quite different from the in vivo situation (see Figure 2A ): (a) In vivo,
the orientation and migration of cells is orchestrated in part by gradients of soluble factors [50,51].
In 2D culture, however, factors are typically homogeneously dispersed throughout the medium.
This means an important signalling mechanism is absent. For example, soluble growth factors
have been demonstrated to guide neuron migration and dendrite extension [51]. (b) The substrate
is typically much stiffer than natural matrix in vivo, the flatness of the substrate forces a polarity
(i.e., a one-sidedness) on the cells which is unnatural. Since the distribution of adhesion sites on the
cell membrane is important for regulating cell function, these changes in cell geometry can directly
impact cell function. (c) Natural extracellular matrix (ECM) is a complex environment containing
arrangements of different proteins structured at the micro and nanoscale. Meanwhile, 2D culture
is typically conducted on bare surfaces, or on a monolayer of a particular cell adhesion protein
(e.g., collagen type 1, laminin or fibronectin). (d) In the body, the spreading of cells is constrained since
the cells are ‘packed in’ by surrounding ECM. On 2D surfaces, however, the cell is unconstrained in
the x-y plane, and is free to spread. Such spreading creates particular stresses in the cell body that
are particular to the 2D situation. In particular, anchorage dependant cells such as neurons require
adhesive interactions with neighbouring cells and ECM to recapitulate normative cell morphology
in vitro [52,53]. (e) In the body, cell adhesion sites surround the cell, while in 2D these adhesion sides
are restricted to the x-y plane [54–56]. The distribution of adhesion sites is known to impact cell
function. (f) Finally, the mechanical properties of 2D substrates for cell culture are typically far higher
(i.e., orders of magnitude higher) than exist in the body. Substrate stiffness is known to influence cell
function, and the differentiation of stem cells in particular [42,56].
In addition to these considerations of how the microenvironment affects cell behaviour in 2D
versus 3D, the dimensionality itself can have profound effects on how cells communicate. Neurons
grown in 2D can only form synaptic connections with cells along one plane, meanwhile neurons grown
in 3D culture can connect with surrounding neurons in all three dimensions (see Figure 2A). Lai et al.
(2012) compared 2D and 3D cultures of mouse superior cervical ganglion neurons to freshly dissected
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ganglion tissue. Calcium flux assays demonstrated that in response to high potassium depolarization
the intracellular calcium release of 3D cultured neurons was strikingly similar to that of neurons in the
freshly dissected tissue; whereas 2D cultured neurons showed a significant increase in intracellular
calcium release in comparison [57]. Immunostaining revealed that voltage gated calcium channel
(VGCC) distribution in 2D cultured neurons were found to be tightly clustered together on the plasma
membrane, whereas in 3D cultured and tissue neurons they were diffused over the plasma membrane;
abnormalities in VGCC have been implicated in epilepsy (Zamponi et al., 2010), further emphasizing
the need for 3D epilepsy disease models. Lai et al. (2012) demonstrated that membrane architecture and
signalling behaviour are altered in 2D, but not 3D cultured neurons compared to that of native tissue.
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(B) Network f rmation in 2D and 3D. Bourke et al. (2018) cultured day r t ryonic cortical in
collagen type I 2D and 3D cultures. Schematic of 2D (B1) and 3D (B4) network formation, red indicates
network activation. Immu ofluoresence of 2D cultures (B2) and 3D cultures (B5) imaged at 35 days
in culture. Micro electrod array (MEA) recordings from the neuro al networks f 2D (B3) cultures
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Bourke t l. (2018) grew embryonic day 18 rat hippocampal cells in both 2D culture and as
a 3D culture. The electrophysiological behaviour of neurons within both cultures was assessed
via microelectrode array (MEA) at 35 days of culture (Figure 2B). Both 2D and 3D cultures were
demonstrated to have glutamate sensitive neurons present with synchronous firing periods [58].
However, the 2D culture exhibited a short repetitive bursting pattern with each activation of the
pace making region resulting in a single short burst at each electrode. In comparison, the 3D culture
exhibited bursts of extended duration interspersed by dormant periods. The pattern of extended
bursting indicated oscillatory activation through multiple network pathways of differing path lengths,
demonstrating the establishment of extensive network formation throughout the collagen gel. Magill
et al. (2000) reported a similar extended bursting pattern in the rat hippocampus in situ [59], therefore
Bourke et al. (2018) demonstrated that neurons in 3D culture form functional networks that are not
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achieved in 2D. The implication is that neurons in 3D culture mimic the electrophysiological behaviour
of neurons in vivo much more closely than neurons cultured in 2D, as illustrated in Figure 2B.
2D hydrogel cultures of astrocytes have also been demonstrated to yield lower populations
of early astrocyte marker GFAP+ compared to 3D cultures, where astrocytes have a tendency to
overgrow [60,61]. Cell morphologies remained round in 2D cultures compared to the stellate and
perivascular-like cells observed in 3D cultures, which resemble the morphology of early astrocytes
in vivo [60,62].
2.2. Biomaterials Requirements for 3D Neuronal Culture
To achieve 3D culture, cells are typically encapsulated in a hydrogel biomaterial which plays an
early role as a rudimentary ECM [54–56]. The ideal biomaterial would be biomimetic of the target
tissue when cultured in 3D, mimicking the mechanical, structural, biochemical, and diffusive properties
of the target tissue, while remaining biocompatible with cells [50,63]. Here, we will discuss some of
these requirements in turn.
2.2.1. Mechanical Characteristics of the Brain
To fabricate an anisotropically accurate model of the brain in vitro presents a formidable tissue
engineering challenge. The brain is arguably the most highly complex organ in higher vertebrates,
and is also extremely soft, with an elastic modulus of less than 1 kPa [64]. As a structure the brain is
not stiff enough to support its own weight under gravity; being supported by cerebrospinal fluid in
situ [64]. Cell density also plays a role in the stiffness of the brain; as cells proliferate the stiffness and
amount of ECM components secreted by the cells increases [56,65]. The influence of the mechanical
environment on neural differentiation has been observed in vitro, with softer environments <500 Pa
promoting the differentiation of adult neural stem cells (NSCs) towards a neuronal lineage, whilst
stiffer substrates (1000–10,000 Pa) promote glial differentiation [42].
2.2.2. ECM Composition of the Brain
The development and differentiation of precursor neural cells in vitro is a recapitulation of
the development on the brain in utero. Thus, in vitro constructs aim to mimic the foetal brain
microenvironment. Sood et al. (2016) characterized foetal and adult porcine brain ECM and found
that foetal ECM was comprised of 417.8 µg/mg collagen and sGAG 406.6 µg/mg, whilst adult brain
ECM had a pointedly higher sGAG to collagen ratio, with less collagen at 200.9 µg/mg, and sGAG
concentration of 397 µg/mg [54]. Sood et al. (2016) demonstrated via protein gel electrophoresis that
the collagen in both adult and foetal ECM was predominantly collagen type 1 [54]. Yet it is still largely
unknown what the function of the collagens; and other fibrous ECM components such as fibronectin
and vitronectin; are in the brain [66,67]. Certainly, different integrin binding sites play an important
role in multiple signalling pathways [68,69]. Foetal brain tissue is markedly more gelatinous and less
viscoelastic than adult brain tissue [70]. The replacement of foetal ECM proteins with homologous
adult ECM proteins confers a stiffer and more robust nature to the adult brain [71].
This native composition suggests hydrogels as suitable materials for formulating in vitro neural
culture, in particular collagen type I and hyaluronic acid.
2.2.3. Microfluidic Devices: Drug Screening and Disease Modelling
Microfluidic devices, also called ‘organ-chips’ or ‘lab-on-a-chip’, consist of several microchannels
with volumes of microliters or picolitres, and can be fabricated with interconnected compartments
containing 2D or 3D neural culture environments. Designed compartments allow individual cell
analysis of cell secretions, protein, and gene expression. Channels can enable fluid flow that can
introduce gradients and model the dynamic in vivo environment [72,73]. Microfluidic devices have
been used for drug screening applications and in-depth study of cell behaviour in varying disease
or injured states with high throughput capability [74]. Meanwhile embedded MEAs can facilitate
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the study of neural network dynamics, signalling behaviour and fluid perfusion [73,75–78]. A few
examples are mentioned here, and Osaki et al. (2018) provides a detailed discussion of microfluidic
disease modelling of the CNS [79].
Wevers et al. (2016) used the commercially available OrganoPlate® to culture human iPSC derived
neural progenitor cells (NPCs), glial cells, and neurons embedded in Matrigel. OrganoPlate® consists
of 96 tissue ‘chips’, which have four wells that feed via capillary action into channels: A gel inlet well,
medium inlet well, medium outlet well, and an observation window. Functional neurons formed
with network formation was assessed by Ca2+ imaging. The neurotoxins 2,5 hexanedione, endosufan
and methylmercury were added to media in varying concentrations, and their effects on cell viability
were assessed, however the effect on neurite outgrowth was only reported for methylmercury [80].
The 96 chips allow for high throughput testing of various compounds, which could be applied to
patient derived iPSCs to allow personalized drug screening.
Microfluidic devices have also been used for ex vivo study. Hippocampal slice cultures
spontaneously develop seizures within a week after dissection and are used as in vitro models of
post-traumatic epilepsy [81]. Liu et al. (2019) developed a six-well microfluidic device with incorporated
MEAs to obtain electrophysiological recordings from six hippocampal slices simultaneously, reducing
the variability between controls and experimental replicates in drug screening assays. Twelve small
molecules of receptor tyrosine kinases were screened using this platform. First, the drugs were screened
by biomarker assays for lactate and lactate dehydrogenase, which have been associated with seizures
and seizure induced cell death; raised levels were found with several of the tested drugs. MEA
recordings showed only two drugs, EGFR/ErbB-2 inhibitor and cFMS inhibitor, to have significant
reduction in seizure-like electrical activity [81]. While potentially useful for drug screening, animal
derived ex vivo models have some of the same limitations as animal models, in addition to difficulties
in maintaining long term culture.
3. Biomaterials for 3D Neuronal Culture Models
Here, we survey research into developing hydrogels for 3D culture of neurons. Hydrogels consist
of hydrophilic polymer chains that crosslink to form a network. Hydrogels are an attractive material
for culturing cells in 3D due to their biocompatibility, high water content, and tunable physical and
chemical properties. Mechanical stiffness and pore size are tunable in many hydrogels to match
hydrogel properties with the in vivo cellular environment [82,83]. In the case of neurons, the pore
structure of the hydrogel must be able to support neural cell bodies, which are 10–50 µm, [83] while
allowing the process of neurite extension [84]. Interconnected pores facilitate mass transport of cellular
nutrients and metabolic waste [83].
Typically in the cell encapsulation process, cells are mixed with hydrogel precursors, which are
then crosslinked via chemical means or changes in pH or temperature, with cells being encapsulated
during the gelation process [85]. Neuronal survival is affected by many factors such as cell–cell
interaction, soluble survival and growth factors, and signals from the ECM [84,86]. Natural hydrogels
such as collagen often contain naturally occurring ECM signals, whilst other hydrogels require
additives containing ECM signals to allow neuron survival [84]. The mechanical characteristics of
the gel, i.e., stiffness and porosity, and ability to support neural growth and network formation are
important factors for choosing which biomaterials may be useful for neural cultures. The assessment
of electrophysiological activity to establish functionally active neurons and neural networks is critical
to attain functional outcomes from biomaterial-based neural cultures, however many studies focus
primarily on cell viability and morphology (Table 1). Electrical stimulation has been demonstrated to
trigger or accelerate the differentiation of stem cells towards neural lineages [87–91], however we limit
the scope of our discussion to biomaterial culture without such exogenous stimuli.
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3.1. Collagen Based Materials
Collagen type I, hereafter referred to as collagen, is extracted from animal sources and stabilized in
liquid form in acetic acid, it can then be crosslinked through a pH change or with chemical crosslinking
agents such as genipin [58,92]. The mechanical properties of collagen are tunable via the manipulation
of crosslinking agents and collagen concentration. Neurite growth has been observed to be more
pronounced in collagen gels of lower concentration [20,58,93] (Figure 3E–H). The pore size of 3D
collagen hydrogels decreases with increases in collagen concentration; and neurite extension tends to
increase with larger pore size [94]. 3D bulk collagen gels have been shown to support neuron growth
for over a month with functional neural network formation [58]. Functional network formation requires
interconnecting extensive neurite extension, which was achieved in very low collagen concentration,
0.04% [58]; confirmed via MEA. Extensive interconnecting networks formed due to the very soft
nature of the gel; this concentration was found to have a complex dynamic modulus of 10 Pa at this
concentration [95].
As described above, collagen I is a native component of brain ECM in vivo, and provides binding
sites encouraging neurite outgrowth such as RGD and target sequences of matrix metalloproteinase
(MMP) [95]. The protein laminin is an ECM component that is often added to hydrogels to promote
neuron adhesion, however the incorporation of laminin to 3D collagen gels has been demonstrated
to (a) not affect the mechanical stiffness and (b) limit neurite extension in contrast to collagen only
3D gels; whereas laminin addition improves neurite extension in 2D collagen cultures [95]. Neurite
growth has been observed to be more pronounced in collagen gels alone in comparison with collagen
gels combined with either laminin or fibronectin [96].
3.2. Hyaluronic Acid Based Materials
Hyaluronic acid (HA) is a hydrophilic nonimmunogenic long chain polysaccharide found in the
ECM of connective tissue; it is also integral to the structure of the CNS [54,97]. The foetal brain is
rich in HA, where HA synthesis is upregulated along NPC migratory routes [40]. HA itself has a
role in inflammation regulation: Low molecular weight HA is pro-inflammatory and high MW HA
is anti-inflammatory [97]. High MW HA has been demonstrated to limit glial scarring after spinal
cord injury or brain damage [98]. Many cell types including NPCs express the HA receptor CD44
acting as a mechano-transduction sensor; the addition of ECM motifs is often used to encourage cell
development [40,99,100].
HA concentration can be altered to create bioinks with tunable mechanical characteristics without
changing the pore size of the scaffold [13,101]. In its native form HA is rapidly biodegradable in vivo
by cell secreted hyaluronidase [97]. For use in 3D modelling HA is often covalently crosslinked to
form an insoluble hydrogel to increase its stability as a biomaterial scaffold [99,102].
One of the most popular techniques to covalently crosslink hyaluronic acid is to functionalise the
polymer chains with methacrylate groups, which can be photocrosslinked through a photo-induced
free-radical polymerisation reaction. Higher degrees of functionalisation result in stiffer gels and
slower degradation via hyaluronidase [102]. The duration of photo crosslinking can determine the
stiffness allowing another method of manipulation of the mechanical properties of methacrylated
hyaluronic acid (HAMA) [103].
Softer HAMA 3D cultures drive NPCs towards a neural phenotype, whereas HAMA 3D
cultures with stiffer mechanical properties akin to an adult brain favoured NPC differentiation into
astrocytes [102,103]. Functionally active GABA and glutamate responsive neurons were established in
3D HAMA hydrogels supplemented with RGD, YIGSR, and IKVAV [40] (Figure 3I).
Another strategy to achieve covalent crosslinking is thiolated HA (HA-SH), which has been used
to synthesise gels with storage modulus comparable to native brain tissue at 188± 42 Pa [102]. However
at 70 days neurons were not functionally mature with cells displaying embryonic electrophysiological
behaviour. HA has also been enzymatically crosslinked via the transglutimase activity of FXIIIa
(Ha-TG) to create a 3D neural culture from rat embryonic cortical cells. The storage modulus of 100 Pa
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was soft enough to allow neurite extension with cell dendritic spines emerging after Day 5 [104]. Long
term coordinated and spiking calcium activity was observed in multiple cells, suggesting functional
neural network formation with glutamate responsive neurons.
3.3. Other Hydrogels
3.3.1. GelMA
Gelatin is hydrolyzed collagen and therefore shares many of the same ECM peptide motifs as
collagen such as RGD and MMP sequences promoting cell adhesion. Gelatin methacryloyl (GelMA)
is a hydrogel which covalently crosslinks via photoinitiated radical polymerization. GelMA is
relatively tunable; both pore size and compressive modulus can be modulated by varying the degree
of methacryloyl substitution [105]. However, GelMA cannot form stable, contiguous gels below a
concentration of about 5% w/v, and so achieves compressive moduli on the order of 1000 Pa at its
softest [106]. PC12 neuronal cells and NPCs encapsulated in GelMA have healed mouse brain injury
and lead to significant functional recovery in murine spinal cord injury (SCI), respectively [107,108].
Neurons from the gigantocellular nucleus have been encapsulated in 3D hydrogel combination of
GelMA/HAMA both with and without the addition of laminin exhibited dendritic extensions, expressed
β tubulin III confirming neural phenotype, and three-dimensional distribution throughout the hydrogel
with network formation [109] (Figure 3J).
3.3.2. Agarose
Agarose is a non-toxic polysaccharide derived from seaweed that has been utilized as a material
for 3D neural cultures. However, agarose networks are lacking in suitable cell attachment sites, and
are not suitable for neuron adherence and survival [84] (Figure 3A–D) so agarose based neural cultures
require supplementation with ECM proteins. Modification of agarose with covalently bound laminin
via the bifunctional crosslinking agent 1′ 1 carbonyidiimidazole improved neurite extension in PC12
and dorsal root ganglion (DRG) cells [110].
3.3.3. Chitosan
Chitosan is a polysaccharide derived from the exoskeletons of shellfish. Carboxymethyl chitosan
(CMC) functionalized with methacrylate groups can reach compressive moduli in the range of 10–400 Pa,
comparable to brain tissue, depending on concentration [64,111]. 0.5% chitosan 3D gels supported
neurite outgrowth of encapsulated DRGs and hippocampal neurons. Chitosan is positively charged
which promotes cell attachment and differentiation, especially into glial cells, even in the absence of
ECM cues [111] (Figure 3K).
3.3.4. Alginate
Algae derived alginates can be ionically crosslinked via the addition of a divalent cation such as
calcium to form a hydrogel network. Palazzo et al. (2015) developed alginate hydrogels with storage
moduli ranging from 10–4000 Pa, depending upon the alginate concentration and the concentration of
the calcium crosslinker added. The lowest concentration of alginate, 0.1% had a storage modulus of
10 Pa with 83% of encapsulated rat primary cortical neurons viable after three days [112]. Calcium
flux showed spontaneous activity in multiple cells with synchronized bursting indicative of functional
neural network formation [112], however without challenging the cells with signal blockers it cannot be
confirmed that the calcium spiking activity was from neural electrical activity alone. Interestingly, 0.2%
alginate hydrogels had a storage modulus of 100 Pa with lower viability and less pronounced firing
patterns compared to the softer 0.1% gel. This study illustrates that the softer the 3D matrix is the more
amenable it is to the formation of neural networks, despite the lack of ECM integrins [112]. This study
also highlights the differences between 2D and 3D culture, in 2D cultures 10 Pa environments decrease
neural maturation [42].
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3.3.5. Matrigel
Matrigel is a viscous protein-rich secretion from Engelbreth-Holm-Swarm (EHS) mouse sarcoma
cells that contains many ECM components [113]. Irons et al. (2008) co-cultured embryonic
cortical neurons with astrocytes to create a 3D neural model using commercially available
Matrigel [61]. Extensive neurite outgrowth was observed and patch clamp recordings evidenced
neuron functionality [61]. However, Matrigel is known to suffer from batch to batch variability, so 3D
cultures consisting of Matrigel may lack reproducibility [113].
3.3.6. Fibrin
Fibrin hydrogels are produced from fibrinogen, which is derived from plasma containing Factor
XIII, and crosslinks via the enzymatic activity of thrombin. Increased fibrinogen concentration results in
gels of higher stiffness and decreased pore size, fibrinogen concentration 4 mg/mL, 6 mg/mL, 8 mg/mL
and 10 mg/mL resulted in pore sizes of 0.71 µm, 0.65 µm, 0.53 µm and 0.49 µm; and elastic moduli
of 400 Pa, 700 Pa, 1000 Pa and 1200 Pa [114]. Bento et al. (2017) established 3D fibrin hydrogels
embedded with neural stem/progenitor cells (NSPCs) derived from mouse embryonic stem (ES)
cells [114]. A range of fibrinogen concentrations were explored, with elastic moduli from 400–1200 Pa.
While fibrinogen concentration did not significantly affect cell viability, lower concentrations formed
dense extensive neural networks (Figure 3L). After 14 days NSPCs were secreting ECM proteins
laminin, fibronectin, and collagen type IV, and actively remodelling the microstructure of the fibrin gel
using matrix metalloproteinases (MMP) and matriptase [114].
3.3.7. Poly(ethylene glycol) (PEG)
Synthetic poly(ethylene glycol) (PEG) hydrogels have been used to develop multicomponent
neural constructs that mimic brain tissue [18]. Thiol-ene photopolymerization was utilized to crosslink
8-arm PEG-norbornene molecules with RGD and MMP-degradable peptides to promote cell adhesion.
Neural progenitor (NP), endothelial and microglial cells derived from iPSCs were added to the
culture at different times to mimic brain development in vivo. Genetic analysis showed that NPs in
multicomponent cultures had more uniform gene expression compared to NP only constructs; this
method is an alternative to organoid generation as the cellular organisation and gene expression
profiles were highly reproducible [18].
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Agarose 0.5% NA Day-18 rat cortical neurons 14 days No NA [84]
Agarose 1.0% NA DRGs 6 days No NA [110]
Alginate 0.25% 180 Pa(G’) Rat hippocampal NSC 7 days No NA [115]
Alginate + PLGA
microspheres 1.0% NA Rat hippocampal NSC 8 days No NA [116]




CMC 0.5% 104 ± 13.46 Pa(G’) Rat hippocampal corticalneurons, DRGs and NSCs 14 days No NA [111]
Collagen type I 0.04% NA Day-18 rat cortical neurons 10 days Yes NA [84]
Collagentype I 0.3% NA NPCs 30 days No Yes individual neurons only1 [93]
Collagen type I 0.2% 57–377 Pa (G’) Chick dorsal root ganglions 5 days NA NA [117]
Collagen type I 0.04% 10 Pa (G*) Rat dorsal root ganglions 24 h NA NA [95]
Collagen type I 0.04% NA Day 13 rat cortical andsubcortical neurons 24 days Yes
Yes, neuron whole cell
patch clamp [20]
Collagen type I 0.04% NA Embryonic day-18 rathippocampal neurons 35 days Yes
Yes, networkmultiple sites
connected MEA [58]
Collagen type I 0.1% NA Embryonic day-18 rathippocampal neurons 21 days Yes
Yes, neuron whole cell
patch clamp [118]
HA-SH + peptides 4–6% 188 ± 42 Pa (G’) H9 human embryonic stem cells 10 weeks No No, patch clamp recordingcells immature [100]
HA-SH+RGD 3% 400 Pa (G’) Embryonic mouse hippocampalNPC 21 days NA NA [99]
HAMA (+peptides) 1% 130 Pa (E)
NPCs from normal and Rett
syndrome patient derived
hiPSCs
3 weeks Yes Yes, neuron whole cellpatch clamp [40]









HAMA 0.5% 200 Pa (Ec) mixed glial cells 14 days No NA [13]
HAMA 0.5% 510–1410 P (Ec)
NPCs from normal and Down
syndrome patient derived
hiPSCs
28 days No NA [103]
HAMA 1.5% 3000 Pa (Ec) Rat ventral midbrain NPCs 14 days No NA [102]




GelMA/HAMA (3.5/0.5%) 1100 Pa (Ec) E12.5 hindbrain cell 15 days Yes NA [109]
Matrigel 0.05% NA Rat embryonic cortical neuronsand astrocytes 60 days NA
Yes, neuron whole cell
patch clamp [61]
GelMA 4% and8% NA PC12 cells 7 days NA
Maybe, healed mouse brain
injury [107]
GelMA 3% 680 Pa(G’) iPSC derived NPC 7 days NA Maybe, restored functionalrecovery after SCI [108]
Fibrin 0.4–1% 400–1200 Pa (G’) Mouse embryo derived NPSC 14 days Yes NA [114]
PEG +RGD+MMP
degrading peptides 4.4% NA
iPSC derived NPC, EC and
microglial cells 21 days NA NA [18]
Notes: NA: Not assessed. G’ = storage modulus; G* = complex dynamic modulus, E = Elastic (Young’s) modulus; Ec = compressive modulus; 1 Functionality is inferred in calcium flux
assay; 2 without challenging the cells with signal blockers it is unconfirmed that the calcium spiking activity was from neural electrical activity alone.
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3.4. Disease Modelling in Bulk Gels
3D hydrogel cultures have been developed as brain disease models, using patient derived iPSCs
or via manipulation of culture conditions. Although bulk gel 3D cultures lack the microarchitecture
of native tissue, valuable insights have been gained via bulk gel disease models. High molecular
weight HAMA has been utilized to develop 3D models of glial scar formation, with an elastic modulus
similar to that of native brain tissue of 200 Pa [13]. Neural behaviour is often the focus in epilepsy
research, however the formation of glial scars in response to trauma is thought to be a leading cause of
acquired epilepsy [119]. Surgical removal of glial scars has alleviated seizures in cases of drug-resistant
epilepsy [119] suggesting that the role of glial scars in epileptogenesis is an avenue for further study.
To explore neural migration in Rhett syndrome, a symptom of which is epileptic seizures, patient
derived iPSCs were compared to nonaffected parental control derived iPSCs. Rhett syndrome is
attributed to mutations in the gene encoding methyl-CpG-binding protein-2 (MeCP2) [40]. Patient
derived NPCs only migrated 70% compared to the migration of parental control NPCs. Patient
derived neurons exhibited decreased neurite outgrowth and less synaptic connections compared to
controls [40]. When MeCP2 function was restored in patient derived cells the migratory behaviour of
NPCs was rescued, indicating that inhibited neural migration due to defective MeCP2 during early
neurodevelopment contribute to the pathology of Rhett syndrome [40].
Approximately 5% of people hospitalized for traumatic brain injury (TBI) develop post-traumatic
epilepsy (PTE) [120]. Al Rifai et al. (2015) implanted PC12 neural cells encapsulated within a 4% and 8%
GelMA into mice that had sustained TBI; one week after implantation the injury had disappeared [107].
In vitro after three days axon like projections were observed; after seven days the implanted constructs
stained positive for PC12 markers and were found to be non-immunogenic and non-inflammatory [107].
In a model for the pathogenesis of Alzheimer’s disease, 3D collagen matrix with embedded
β-amyloid aggregates was seeded with PC12 cells, no toxicity was observed when cells were separated
from β-amyloid aggregates [94]. Only upon addition of collagenase did neurites extend into the
gel, neurites within 1 µm of β-amyloid aggregates exhibited stopping or turning behaviour. When
cell bodies were cultured close to β-amyloid aggregates there was low cell viability and no neurite
extension [94], these results demonstrate that the toxicity of β-amyloid aggregates is dependent upon
the proximity to neurons. In another β-amyloid study human iPSC derived NPCs were embedded in
the commercial 3D hydrogel PuraMatrix, a self-assembling RADA-16 peptide that crosslinks upon
exposure to cations [74,121]. Treatment with β-amyloid peptides was found to significantly lower NPC
expression of proteins for actin stabilization and mechanotransduction pathways, drebrin and p21
activated kinases (PAK), respectively. In untreated NPCs, activated PAK and drebrin were localized in
the nucleus and cytosol, and NPCs treated with β-amyloid peptides caused activated PAK and drebrin
to be sequestered to submembraneous regions [121,122].
Choi et al. (2014) used retroviral vectors to engineer NPCs that overexpressed familial Alzheimer’s
disease mutations to produce high levels of β-amyloid peptides. Engineered NPCs were embedded in
3D Matrigel, and high levels of β-amyloid and hyper-phosphorylated tau accumulated in six weeks,
compared to 2D cultures where β-amyloid peptides diffused into culture media. Application of β and γ
secretase inhibitors significantly lowered β-amyloid levels and also tau, demonstrating that high levels
of β-amyloid peptide contribute directly to tau pathology [123]. This link had not been shown with
animal models or 2D models [74,123], demonstrating the advantages of in vitro 3D disease modelling.
4. Strategies for Biofabricating Neural Models
Layered neural models of neurons encapsulated in bulk gels have provided insights on neural
migration and neurite extension. Although 3D constructs can be created by simply pouring a bulk gel
into a cast with high fidelity to the desired form, referred to as cast moulding [124], cell placement
within the gel is random, and cells tend to settle at the base of the mould prior to gelation or clump
together. Larger 3D bulk gels show necrosis at the core due to limited diffusion [61]. Other methods of
neural biofabrication include microfluidic technology and using 3D scaffolds. Many different types of
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3D scaffolds have been developed for 3D neural culture; materials vary greatly including hydrogels,
glass, and polymers. Most microfluidic devices use 2D cell culture, however some 3D models have been
developed for drug screening and disease modelling, discussed later in the disease modelling section.
4.1. Layered 3D Neural Models
Layered 3D neural models are formed by crosslinking one layer of a bulk gel prior to deposition of
the next layer. These structures are typically created through manual pipetting, and so represent a link
between the bulk 3D gels already discussed, and the more robotically controlled bioprinters to follow.
Layered models have demonstrated that cell seeding onto 3D gels is inferior to cell encapsulation in 3D
gels in recapitulating in vivo neural morphology [118]. Layered models have been used to demonstrate
that neurite extension is increased towards NGF in 3D [110]. A layered model demonstrated that
NPCs migrate toward astrocytes in 3D and showed defective cell migration in patient derived MeCP2
mutant cells as a disease model for Rhett syndrome [40].
4.2. Gradients in 3D Bulk Hydrogels
Durotactic gradients, gradients of increasing stiffness, were demonstrated to promote neurite
extension compared to gels of uniform mechanical properties [117]. Similarly haptotactic gradients,
gradients of bioactive molecules, of YIGSR and IKVAV were demonstrated to promote neurite outgrowth
in a synergistic manner in 3D [51]; in agreement with findings in 2D cultures [125,126].
4.3. 3D Scaffolds
3D scaffolds serve as a rudimentary structure to guide cell growth via topographical cues; cells
are seeded onto pre-formed scaffolds. A myriad of techniques has been developed for neural scaffolds
with applications ranging from disease modelling to therapeutic implants. Herein, we describe neural
scaffolds with a focus on guided neurite growth, mechanical and electrophysiological properties.
Colloidal scaffolds consist of layers of microbeads; silk scaffolds have served as moulds for bulk
hydrogels; methods to create macroporous scaffolds have been developed and electrospinning has
been used to guide neurite extension.
4.3.1. Colloidal 3D Scaffolds
Colloidal scaffolds consist of layered microbead bead arrays, beads of silica [127], glass [128], and
chitosan [129] have been used in the fabrication of 3D scaffolds. In such colloidal substrates, neural
processes spread along and between the beads and network activation through different layers has
been demonstrated with calcium flux assays [127] and MEA recordings [128,129]. Neurites, however,
can only extend along bead surfaces, limiting cell–cell interaction and network activation between
layers, with diminished connectivity in the z direction between layers slowing response to evoked
potential [128]. Burst amplitude between the 2D control and 3D scaffold recordings were of a similar
amplitude, the burst duration was longer with an often-delayed response for the 3D recordings [128].
Stimulation from electrodes at the top of the scaffold had delays of 500 ms due to the transmission down
the neurons of the different layers to the bottom read-out layer in contact with the MEA [128], indicating
less effective connectivity in the z direction. Tedesco et al. (2017) found similar results but with
increased random spiking in neural cultures seeded within 3D colloidal hydrogel scaffolds composed
of chitosan microbeads, and detected the synaptic vesicle protein synapsin at day 25 [129]. Neurites
penetrated soft chitosan microbeads to a limited extent, whereas neurite extension was only upon the
surfaces of glass or silica microbeads [127–129]. Microbeads of 0.1% and 0.2% chitosan scaffolds, were
~0.08 kPa–1.3 kPa and 15 kPa–25 kPa(elastic modulus), respectively; the softer scaffold showed more
extensive network formation and functionality, demonstrating the importance of mimicking the brains
in vivo mechanical environment [56,64,129]. However, the electrophysiological results of neuronal
network formation in a bulk hydrogel collagen more closely resembled that observed in living brain
tissue [58,59].
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4.3.2. Silk Scaffolds
The silk from silkworm cocoons can form a sponge like material with pore size ~500 µm and
is stiff enough to be self-supporting. Tang-Schomer et al. (2014) developed 3D silk scaffolds with
compartmentalized layered architectures as a cerebral model: Axon only ‘white matter’ in the centre
and neurons in the outer layers as ‘grey matter’. [130]. Collagen hydrogel infusion followed seeding
with primary cortical neurons. Another study found improved cell viability, network density, axon
outgrowth, and accelerated functional neural maturation of 3D silk scaffold collagen composite
constructs in the presence of adult decellularized ECM. These effects were enhanced further by the
addition of foetal decellularized ECM and astrocyte derived matricellular proteins [54].
4.3.3. Macroporous Scaffolds
Macropores are large pores acting as interconnected channels to facilitate mass transport and cell
penetration throughout a 3D construct. Macropores can be fabricated using a pore creating agent,
called a porogen [83,131]. For example, gaseous salt leaching involves combining a viscous polymer
solution with salt crystals as a porogen in a mould; and evaporating the liquid, leaching out the salt,
resulting in a hard-porous structure. Salt concentration and crystal size determines the porosity of
the resulting scaffold [131]. Neurons have been shown to be viable but did not proliferate within
a gas leached scaffold, probably due to the rigidity of the scaffold [57]. Nonetheless this method
demonstrated the exaggerated responses of neurons cultured in 2D in calcium flux assays, compared
to the high degree of similarity between 3D cultures and freshly dissected tissue [57].
Cryogels are macroporous hydrogels where crosslinking occurs at subzero temperatures, ice
crystals act as porogens, disrupting the crosslinking of the hydrogels, and once thawed leave macropores
within the interconnecting micropores of the hydrogel [132]. Due to the macroporous nature of cryogels
they reversibly collapse under shear force, allowing them to recover their original crosslinked 3D
shape after being passed through a syringe [133], referred to as shape memory. Alginate cryogels have
been demonstrated to have compressive modulus of 4 kPa compared to a bulk alginate hydrogel of
42 kPA in the same concentration of alginate and same 3D shape [133]. Neural networks and cell
morphology of differentiated neurons were preserved even after compression and extrusion through a
needle [134]. Jurga et al. (2016) developed a 3D gelatin laminin cryogel seeded with stem cells from
human umbilical cord blood cells (CBSCs); which when transplanted into rat brains were found not
to induce inflammation or microglial activation, and prevented astrocytic scar formation [135]. Pore
sizes varied from 20 to 160 µm, with pores < 100 µm required for cell–cell contact. CBSCs expressed
MAP2, Nestin, and GFAP in medium sized pores, demonstrating their differentiation into neuronal
and glial cell types due to good morphogen penetration. In smaller pores the stem cells remained
undifferentiated, demonstrating the importance of pore size optimization for stem cell differentiation
in 3D scaffolds [135].
A major limitation with such macroporous gels is that the low temperature or high salt
concentrations, critical to the construction technique, are damaging to cells, so cells can only be
added after the gel is fully formed, limiting cell encapsulation as a seeding method.
4.3.4. Electrospun Scaffolds
Electrospinning is a technique used to create fine fibres with nano- or micrometer diameters.
The technique involves using electric force to draw charged jets of polymer which are collected on
a grounded collector; stationary collectors result in randomly oriented fibres while rapidly rotating
collectors produce aligned fibres [136]. Electrospun fibres have been demonstrated to guide neurite
extension and increase cell to cell contacts with fibres of polycaprolactone (PCL) and polylactic acid
(PLA) [44,137]; aligned fibres were shown to increase cell viability and long term survival in a planar
model of the synaptic neuromuscular junction. Neurite extension was doubled in 3D hydrogel HA-SH
scaffolds with embedded PCL electrospun fibres and neurite alignment increased 66% when PCL was
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functionalized with gelatin or laminin [138]. Engelbreth-Holm-Swarm (EHS) ECM is derived from
murine sarcoma secretions containing many cell attachment motifs [113]. Neurite length and fibre
tracking were not significantly improved with functionalized PCL electrospun fibres embedded in
EHS ECM [138], suggesting that hydrogels rich in ECM proteins may not be suitable for constructs
where neurite extension is directed by fibres.
Standard electrospinning techniques using a flat static collector or coaxial spinning mandrel result
in a 2D matt of fibres [139,140]. Often electrospun fibres are densely packed, preventing cell infiltration.
Blakeney et al. (2011) developed a method of creating electrospun 3D cotton ball like structures with
low density fibres, using concave non-conductive spinning plates embedded with metal needles to
collect the fibres [139]. Jakobsson et al. (2017) used this method to electrospin a 3D PCL structure
which was seeded with NPCs; interspersed glial (GFAP+), and neurons (MAP2+), with inhibitory
(psd-95+) and excitory (gephyrin+) synaptic proteins and extensive neurite formation were observed
in the lower 100 µm of the 600 µm scaffold [140]. Single channel extracellular electrode recording
demonstrated spontaneous action potentials from some locations, yet other locations were silent, to
confirm functional network activity MEA recordings would be required [140].
Melt electrowriting (MEW) is a technique where polymer melts are directly written in a programable
path, using a layer by layer technique MEW can be used to fabricate 3D electrospun structures [141].
MEW is more reproducible than typical electrospinning which can often have chaotic fibre deposition.
Schaefer et al. (2019) developed a 3D prototype neural model of MEW PCL seeded with fibroblast
embedded Matrigel, and demonstrated that the MEW PCL did not interfere with whole cell patch
clamp recordings [142]. Neurons are more vulnerable to environmental stressors than fibroblasts, in
2D neuron electrophysiological behaviour was found not be affected when seeded on PCL electrospun
fibres [44].
By combining two electrospun polymer inputs, HAMA and HA and/or zero and 3 mM RGD,
in different ratios over the course of electrospinning, durotactic, and haptotactic gradients were
achieved through the 3D scaffold [92]. Cells from chick aortic arch explants infiltrated scaffolds to a
greater degree towards higher concentrations of RGD and lower mechanical stiffness; this method
could be applied to guide neurite extension and migration.
4.4. 3D Printed Scaffolds
3D printing, also called additive manufacturing, creates 3D objects from a digital model by
depositing or patterning material via a layer by layer approach. 3D printing, in this section, refers
to applications where cells are seeded on a 3D scaffold after the printing process. A wide range of
materials can be 3D printed, including hydrogels [143–145]. By creating the digital model from 3D
medical images, complex anatomically correct 3D objects can be printed [146–148]. Computer aided
design (CAD) allows easy modification of designs to optimise scaffold properties [149], such as creating
channels or artificial macropores, which can be varied between prints to determine the optimal sizing
for neural interconnections [143,144]. The most common 3D printing techniques used to create neural
scaffolds for neural tissue engineering include photopatterning, direct laser writing, extrusion printing,
and inkjet printing.
4.4.1. 3D Photopatterning
3D photopatterning refers to 3D printing techniques where light is used to draw a crosslinked
pattern in a photocurable material or resin. Such techniques include stereolithography, which crosslinks
in a point by point fashion until each layer is completed; digital light projection, which illuminates
each layer, plane by plane [105], as well as other variations [144,150].
Photopatterning based single neuron capture in 3D GelMA microgel rings has been developed as
a way to model autapse formation [150]. A projection printing technique has been used to produce
3D polyethlylene gycol diacrylate (PEGDA) and GelMA scaffolds with precise internal geometries
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in a log pile or hexagonal pattern, that supported neuron and neurosphere growth, although large
neurospheres were excluded from the scaffold [144].
Extremely high-resolution 3D patterning can be achieved using multi-photon polymerization
systems, where a beam of ultrafast infrared laser is focused to a point within a volume of
photopolymerizable material. Since the polymerisation reaction requires multiple photons, the
resin only hardens in a very small volume near the focal point [151]. Multi-photon polymerisation has
been utilized to print complex shapes such as microtowers or seashells for neural engineering [152,153].
Melissinaki et al. (2011) fabricated 3D polylactide-based (PLA) scaffolds via this technique; neural
cells adhered to PLA filaments; however neurite outgrowth was not guided by PLA filaments on
crosshatched structures [153]. The high precision of multiphoton polymerisation allows for the
fabrication of complex forms such as 3D seashell models. PC12 cells migrated aligning themselves
with the 3D seashell geometry, neurite extensions were projected between 3D objects with network
interconnectivity [153]. The convoluted geometry of the seashell models appeared to promote neurite
projection more so than the linear crosshatched structure; possibly because in vivo neural morphology
is not orthogonal in nature.
4.4.2. Extrusion Printed Scaffolds
Extrusion based 3D printing uses a robotically controlled syringe to extrude materials in a
filamentous strand; which is written on the fabrication stage in a layer-by-layer approach. Extrusion
printing requires biomaterials to have sufficient rheological properties, such as a high enough viscosity,
to maintain the strand shape prior to crosslinking. Extrusion printing typically has lower resolution
than inkjet or laser systems [154,155].
For neural applications, extrusion printing has been used to create 3D scaffolds from a range of
materials including fibrin, where the aligned microstructure of 200 µm diameter fibrin fibers provided
durotactic cues for Schwann cell alignment mimicking the bands of Bünger that Schwann cells form
following nerve injury to guide axon regeneration. [156]. In another example, researchers extrusion
printed 3D scaffolds from a poly 2-hydroxyethyl methacrylate (pHEMA) hydrogel with varying
rod spacing, finding that a 40 µm spacing was optimal for cell penetration and neurite network
formation [143]. Neural growth was restricted to the top layers in scaffolds with rods 30 µm apart,
while larger spacings resulted in cells settling towards the bottom of the scaffolds [143].
The printability requirements for extrusion bioprinting typically favour materials which are far
stiffer than the brain. However, some strategies have managed to side-step this issue, creating very
soft 3D structures using extrusion printing. For example, Tan et al. (2017) used a cryogenic printing
approach to create cuboid lattices with a compressive modulus of 490 Pa, matching well with stiffness of
brain tissue [157]. PVA and Phytagel were extruded and froze on contact with a steel plate maintained
below freezing temperature and upon completion of printing the temperature was raised, melting the
ice leaving an intact 3D hydrogel suspended in water [158]. This method is yet to be applied to neural
tissue engineering.
4.4.3. Convergent Biofabrication
Recently, photopatterning techniques have been combined with other methods in convergent
biofabrication strategies. For example, Sundararaghavan et al. (2010) combined photomask crosslinking
with electrospun HAMA to introduce vascular like channels within the microporous 3D fibrous scaffolds;
allowing mesenchymal stem cells (MSC) to penetrate throughout the 3D scaffold [159] (poor infiltration
of cells is a recognised drawback of electrospun scaffolds) [140,159]). Lee et al. (2017) combined
electrospinning and stereolithographic techniques by embedding aligned electrospun PCL or PCL and
gelatin composite fibres in 3D printed crosshatched PEGDA hydrogel scaffolds [160]. The integrins
within gelatin, combined with the topographical cues from the electrospun fibres promoted and
guided neurite formation compared to the hydrogels without electrospun fibres, despite the stiffer
environment [160].
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Inkjet printing has also been used to decorate 3D scaffolds created by other techniques, for example
to generate spatially controlled growth factor gradients on 3D hydrogel scaffolds to steer stem cell
differentiation [161]. Patterned cell “tracks” of electrically conductive particles have been inkjet printed
to guide cell and neurite growth [162].
4.4.4. 3D Scaffold-Based Disease Models
A traumatic brain injury (TBI) model was created by dropping a weight from varying heights on
3D silk scaffolds with compartmentalized architectures filled with collagen and encapsulated primary
cortical cells [130]. At 1 min post injury glutamate levels were comparable to the response of a rat
TBI model, in vivo glutamate levels return to preinjury level in 5 min; the reuptake of glutamate by
astrocytes was not recapitulated in this neuron monoculture [130].
Photopatterning 3D GelMA microgel rings has been developed as a way to model autapse
formation; axonal circles developed in singly captured neurons [150]. Autapsic ‘positive feedback’
self-stimulation of excitatory neurons are thought to play a role neural hypersynchrony which may
lead to seizures [108,163].
5. 3D Bioprinting
Interactions among multiple cell types determines the structure and function of all tissues.
The brain is very complex with many regions and sub regions, for example it is estimated that there
are 500–1000 different gray matter regions [164,165]. The major cell types within brain tissue include
neurons, oligodendrocytes, astrocytes, microglia, and endothelial cells, of which there are multiple
subtypes. There are thought to be 50–250 neuronal subtypes [164]. Cell populations and densities
vary between regions in a spatially defined manner orchestrating the tissue structure. For example
neocortical tissue consists of six layers: The lamina molecularis has relatively few neurons, the thin lamina
granularis externa is densely populated with small neurons, the lamina pyramidalis externa has medium
pyramidal neurons, the lamina granularis interna consists of small stellate neurons, the lamina pyramidalis
interna has large pyramidal neurons, and the lamina multiformis has polymorphic neurons [166].
Exquisite spatial control of differing cell populations would be of great benefit for the establishment of
in vitro neural models to mirror the spatial heterogeneity of brain tissue in vivo.
Microfluidic casting utilizing polydimethylsiloxoane (PDMS) chips has been utilized to recreate
complex layered 3D constructs, the dynamic environment offered by perfusion of microfluidic chips is
a major advantage [72,79,167]. However, due to the PDMS chip the method is restricted to layers in a
horizontal configuration [168], only allowing bidirectional analysis of cell interactions. 3D printed
scaffolds have given new insights in neural modelling and have potential therapeutic applications
regarding nerve conduits; but are limited by the seeding process. Cell penetration throughout a
scaffold limits cell patterning and cells often have 2D morphology along scaffold surfaces [143].
Bioprinting refers to applications where cells are formulated within in a printable material called a
bioink. Bioprinting overcomes the limitations of cell seeding techniques; it allows specific controlled
placement of the cell laden bioink in a reproducible manner, allowing simultaneous spatial control of
cells and materials [169–171].
In 3D bioprinting cell laden hydrogels are typically deposited in liquid form in the desired shape
prior to being crosslinked into a gel within minutes [172]. Prior to cell proliferation the bioink serves
as a rudimentary ECM [52,53,155,170,173]. Extrusion printing and inkjet printing are commonly
employed methods of 3D bioprinting. Extrusion based methods typically utilize stiffer gels that are
crosslinked as they are extruded in a string like manner, whereas inkjet-based and microvalve methods
are more suitable for softer less viscous gels as they deposit drop by drop [174].
5.1. The Challenge of 3D Bioprinting of Soft Structures
The goal of 3D bioprinting is to mimic the native microenvironment of in vivo tissue. A major
hurdle to 3D biofabrication of soft structures, such as the brain, is the shaping of soft hydrogels into
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3D structures with high spatial resolution that are an anisotropically accurate mimic of the brain
microstructure. A gel with brain like mechanical properties ~500 Pa will sag under its own weight
due to gravity resulting in a loss of shape due to the extremely soft characteristic of the gel. Soft 3D
scaffolds have been developed with cryogels or cryogenic printing, however cells were seeded on
scaffolds after the exposure to subzero temperatures [133–135,158,175], which is known to affect cell
viability studies [176–178].
A more straightforward approach is to use support structures, which support the soft structure
during printing and during the maturation of cells to prevent deformation of the construct. This
support structure needs to be biocompatible with the printed cells without affecting cell viability.
5.2. Support Structure Methods
Support structures can be classed into two broad categories: Permanent support structures or
sacrificial scaffolds. A sacrificial support involves the printing of a structure, a support matrix, which
can easily be removed after printing, often through a washing step [172]. Therefore, sacrificial scaffolds
support the permanent material as it cures or matures to preserve the 3D printed shape. Metals,
ceramics, and polymers are often used as scaffold substrates. However, the removal or degradation of
these constructs can harm cell viability or result in toxic breakdown products [124,172].
5.2.1. Sacrificial Support Scaffolds
The materials used for sacrificial supports vary greatly, however removal without harming cells is
essential. Sacrificial scaffolds that dissolve quickly or require vigorous washing/flushing for removal
are only appropriate for stiffer more cohesive gels, softer gels tend to disintegrate in the washing
step [179]. Water soluble carbohydrate glass has been extrusion printed for the biofabrication of
vascular junctions [180], melt electrospun sucrose microfibers have been utilized as sacrificial scaffolds
in the biofabrication of interconnected channels for bone defect repair [82].
Hinton et al. (2015) developed a method of 3D printing soft materials called freeform reversible
embedding of suspended hydrogels (FRESH), using a thermoreversible sacrificial support bath; unlike
most 3D printing techniques this method is not restricted to layer-by-layer fabrication as demonstrated
by the printing of a continuous 3D helix [148]. The support bath consisted of a 4.5% gelatin microparticle
slurry, which acts as a rigid body under low shear stress and as a viscous liquid at high shear stress;
meaning there was little mechanical resistance as the printing nozzle moved through the support bath,
yet the extruded hydrogel was held in place. Crosslinking reagents were mixed into the gelatin slurry,
upon completion of printing the gelatin was melted off at 37 ◦C and replaced with culture media
leaving the crosslinked 3D hydrogel. Collagen, fibrin, Matrigel, and alginate hydrogels were printed
at 22 ◦C in complex structures, including hollow chambers with a resolution of 200 µm. An alginate
printed dog bone had an elastic modulus of 102 ± 27 kPa [148]. A concern using this technique with
bioprinting is that the gelatin microparticles are melted off at the same temperature used for cell growth,
so it is limited to fast crosslinking methods. Another study adapted this method using a sacrificial bath
of alginate microparticles and culture media supplemented with xanthan-gum which was removed
via enzymatic action. The support bath was gradually aspirated and replaced with media containing
alginate lyase, and used to bioprint a simplified, mini heart model incorporating living cells [147].
FRESH has yet to be applied to neural cultures. The gentle nature of the technique suggests it may be
suitable for neuron printing, although 3D deposition of extremely soft materials (<100 Pa) is yet to
be demonstrated.
5.2.2. Indirectly 3D Bioprinting
Indirect bioprinting refers to the printing of complex support structures and infusing the support
structure with cells encapsulated in hydrogel [124,173]. Naghieh et al. (2019) indirectly 3D bioprinted
primary rat Schwann cells in varying concentrations of alginate, using a sacrificial gelatin scaffold [181].
A 20 layered gelatin sacrificial scaffold was 3D printed and then impregnated with a cell-laden alginate
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hydrogel. The alginate was crosslinked through CaCl2 addition, before the sacrificial gelatin template
was melted away at 37 ◦C. However, the softest hydrogel, 0.5% alginate, had a modulus of 2.5 kPa; and
degraded within 3 h [181]. Cell viability was increased due to the presence of interconnected pores
created via indirect 3D printing of sacrificial scaffolds [181].
5.3. 3D Bioprinting of Neurons
5.3.1. Extrusion Based 3D Bioprinting of Neural Structures
Extrusion printing is commonly employed in bioprinting due to its economy, ease of use, and
capability to print with high cell density with a wide range of materials [154,170]. Resolution is
dependent upon nozzle diameter typically in the range of 50–500 µm [155].
Parameters such as nozzle diameter, dispensing pressure, and material viscosity during bioprinting
submit cells to the stresses of shear force, tension, and compression; if excessive these forces can result
in deformation and cell damage. Shear stress can be minimized by using lower pressure/propelling
force, less viscous materials, and larger diameter nozzles [155,170]. Cell viability after printing is
therefore often a principal focus of bioprinting studies; functionality is less often assessed.
Lozano et al. (2015) printed discrete layers of polysaccharide gellan gum-RGD (peptide modified
biopolymer) and primary rat cortical neurons. The gellan gum-RGD was crosslinked via CaCl2 or 5x
Dulbecco’s Modified Eagle Medium (DMEM) and three layers were printed with neurons encapsulated
in the bottom and top layer. Axon extensions spread throughout layers penetrating the acellular middle
layer; neurons did not migrate between layers and networks formed within layers only (Figure 4A).
Axon/dendrite extension was slightly improved using DMEM compared to CaCl2, although cells were
more clustered compared to non-printed cast moulded 3D cultures.
Gu et al. (2016) extrusion printed human iPSCs that were differentiated post printing into neurons,
astrocytes and oligodendrocytes, creating a neural mini-tissue 3D lattice (refer to Figure 4C). The bioink
was a composite of alginate, agarose, and carboxymethyl-chitosan (Al-Ag-CMC) crosslinked post
printing via CaCl2 immersion. Printed constructs had a compression modulus of 4.73 kPa which
decreased to 0.8 kPa at 10 days post printing where it stabilized, closer to the stiffness of native
brain [64]. Neurites with interconnections were detected but were limited perhaps due to the 3D
environment being too stiff for optimal neurite outgrowth [182]. Synaptogenesis and functional
GABAergic neurons developed after 24 days. In a later study this technique was used to show that
iPSCs develop into embryoid bodies of three germ lineages when cultured in non-specific cell culture
media [183] (Figure 4B). Differentiation into neural lineages involved culturing cells in media with
specialized media supplemented with neurotrophins to induce an intermediate progenitor phase
followed by a neural maturation phase. Mature neural cells were detected at 30 days post printing
and bicuculline induced synchronous calcium spiking of two cells indicated functional neurons with
possible network functionality at 40 days post printing [183]. This methodology of bioprinting iPSCs
has potential for use in creating patient specific disease models.
Hsieh et al (2015) used fused deposition extrusion printing to bioprint thermoresponsive
biodegradable polyurethane dispersions of PCL diol & poly (D, L-lactide) diol (PU) with encapsulated
murine NSCs; encapsulated 3D constructs were implanted into zebrafish that had sustained brain
injuries [184] (Figure 4D). Remarkably NSC laden bioink of 25% PU was found support NSC proliferation
and to restore function to brain injured zebrafish; coiling rate was restored to 87% of uninjured control
and hatching rate was restored to 67% of uninjured control. Bioinks composed of PCL diol & poly
(D, L-lactide) diol with concentrations <25% were found to be too soft to maintain a 3D form [184].
A notable study conducted by Joung et al. (2018) developed a bioengineered spinal cord combining
bioprinting with 3D printed scaffolds in the only example of functional neurons with extensive axon
propagation from bioprinted NPCs. Spinal NPCs (sNPCs) and oligodendrocyte progenitor cells (OPCs)
bioprinted in precise alternating points within 3D printed single channels, refer to Figure 4E,F and
during the fabrication of 3D printed layered scaffolds [185] (Figure 4G,H). Both sNPCs and OPCs
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were differentiated from iPSCs prior to printing; OPCs were included for spinal cord regeneration
applications as oligodendrocytes support axonal regeneration and myelinate demyelinated axons.
Silicone was printed in single channels of 150 µm diameter and cured for 5 h, then Matrigel laden
bioinks laden with OPCs or NPCs were dispensed separately at 4 ◦C in alternating points with a
distribution resolution of 200 µm. After four days β- III tubulin positive axons spread throughout
the channel. After 14 days NPCs were found to have differentiated into mature glutamate responsive
neurons with functional network formation; inferred from the simultaneous calcium flux recordings
of 10 cells throughout a channel with synchronous responses to K+ and glutamate [185]. Joung et al.
(2018) then used an alginate and methylcellulose (Ag/MC) blend to 3D print a layered 1.5 × 5 mm
scaffold with 3× 3 150 µm wide channels while either the NPC or OPC laden bioink was simultaneously
printed in the scaffold. The scaffold was crosslinked via CaCl2 immersion, cells were viable with some
axonal elongation in all layers three days post printing. Axon propagation of NPCs in the coculture
with OPCs bioprinted in the single silicon channel were increased compared to monoculture NPCs
within the multilayered Ag/MC scaffold; whether due to presence of OPCs, the increased culture
time of one day, or lack of exposure to crosslinking CaCl2 is unclear. Although this is a spinal cord
scaffold the principles of bioprinting during support scaffold assembly could be applied to CNS neural
tissue engineering.Materials 2019, 12, x FOR PEER REVIEW 24 of 41 
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5.3.2. Inkjet Bioprinting of Neurons
Although extrusion is popular in 3D bioprinting it is only suitable for viscous gels, whereas inkjet
deposits drop by drop making it more appropriate for soft gels [187] (Figure 5A). In inkjet printing,
the jetting process is typically controlled by rapidly forcing a droplet of liquid out of a small orifice.
This jetting can be produced either by thermal or piezoelectric control.
Inkjet printing allows higher print resolution with precise cell placement due to the droplets
deposited being in the picolitre range, the challenge with inkjet printing is building layers in the
z direction due to the low viscosity of relevant materials, the only 3D inkjet printed neural model
consisted of stacked layers of 2D patterned gels [118].
In a pioneering work, Xu et al. (2005) utilized a commercial desktop printer equipped with thermal
print heads to print embryonic motor neurons onto a 2D sheet of collagen, forming a neural ring after
two days; and 40 µm dendritic extensions were observed in two cells after seven days [188]. In a later
study, rat hippocampal neurons were thermal inkjet printed onto 2D fibrogen gels. Cells were exposed
to temperatures of approximately 300 ◦C and shear stress of 10 m s−1 for 5 µs, which may account for
the cell viability being only 72.4%, although it should be noted that no non-printed control viability
was reported [189] (Figure 6A). Five layers of thermally inkjet printed fibrin sheets were stacked to
form a 3D structure with a softness of 2.92 MPa, cell survival over 15 days was improved in 3D versus
2D culture [189] (Figure 6B). Electrophysiological behaviour of 2D thermally inkjet printed neurons
were comparable to non-printed controls via patch clamp recording [189]. In contrast to these results
Kador et al. (2019) found that the current required to stimulate action potentials in thermal inkjet
printed retinal ganglion cells (RGC) had to be increased by a third over non-printed controls to elicit
the same response [190]; similar to the electrophysiological properties of axomized neurons in brain
injury models (Greer et al., 2012). Kador et al. (2016) developed a 3D scaffold with PLA electrospun
fibres to guide axon outgrowth in an inkjet printed retina model. Embedding the scaffold in Matrigel
incubated with CaCl2, cells were printed in an alginate bioink, which crosslinked the cells embedded
within the hydrogel scaffold. Neurites were classified as axons if they were long with a consistent
diameter or as dendrites if the diameter was thicker at cell soma with tapered extension. Neurite
outgrowth was aligned with the PLA printed pattern in 71.9% ± 8.2% of axons and 49.3% ± 4.0%
of dendrites after three days [190], however this was reduced compared to 81% axonal alignment
observed on scaffolds simply seeded with cells; which had the same electrophysiological properties as
2D non printed controls [137]. The conditions cells are exposed to in thermal inkjet printing may be
too extreme to apply for the formation of functional neural networks, essential to the development
of disease models of epilepsy; especially because directed axon propagation was not improved by
seeding techniques.
Varying voltage applied during piezoelectric printing was demonstrated to not affect cell viability
or metabolic activity in a 2D model [191] (Figure 6D). For voltages ranging from 70 V to 240 V printed
mouse neuronal NG108-15 cells, human fibroblasts and porcine Schwann cells; had cell viability of
86%–96%, 82%–92%, and 89%–92%, respectively; compared to >90% in non-printed controls [191].
Neural cells could be printed for 40 min before significant loss of cell number due to sedimentation in the
printhead, when pre-flushed with trypsin. By day seven neurite length of printed cells was on average
65 µm, significantly longer than 55 µm of non-printed controls [191] (Figure 6E). Lorber et al. (2013) did
not find that piezoelectric printing advanced neurite length, however length increased by ~190 µm
when RGCs were printed over a layer of printed glial cells demonstrating that glial cells retain their
growth promoting characteristics after piezoelectric inkjet printing [192]. Cell viability was not affected
by piezoelectric printing, the cell population, however, was reduced in printed samples compared to
non-printed controls, by 57% and 33% for glial and RGC, respectively. Imaging during printing of the
printhead nozzle where cells experience the most shear stress showed that cells were not distorted
during printing (Figure 6C). Post jetting imaging showed that a large number of cells had adhered
to the glass capillary walls near the nozzle, suggesting that the reduced cell number was due to cell
sedimentation, as opposed to cell destruction, during the piezoelectric printing process [192]. Whether
Materials 2019, 12, 3218 25 of 42
piezoelectric printing affects the functionality of neurons has not been elucidated and should be an
object of future study.
5.3.3. Other Methods of 3D Printing Neural Cells
Bioacoustic levitation (BAL) is a nozzle free method were cells are levitated by the reflection
and interference of standing acoustic waves; crosslinking methods are required to be rapid to entrap
levitated cells before cell settling occurs [193] (Figure 5B). 3D fibrin gels with multilayered NPCs
produced via BAL had an elastic modulus of 474 Pa, mimicking brain tissue [64,193]. Over 30 days the
neural progenitor cells differentiated into immature neurons, with some neurite extension.Although
by this timepoint neurons had migrated from the distinct layers that were visible at day eight and
some cell settling had occurred towards the bottom of the 3D gel [193] (Figure 6M–O). Perhaps if BAL
was combined with other methods such as electrospinning the neural migration could be controlled.
Microvalve printing is a drop by drop or continuous filament method where droplet formation,
with volumes in the order of 10 nanoliters, is controlled via adjustments to the applied pressure
and valve opening duration (Figure 5A). Printing resolution is determined by the inter-dispensing
distance and drop volume. Lee et al. (2009) used a stepwise layering approach to bioprint neurons and
astrocytes in 3D collagen. Sodium bicarbonate (NaHCO3) was alternated with dispensed collagen
layers and bioprinted cells, completing crosslinking and entrapping cells in their spatially defined
position. For cell patterning at least one acellular collagen layer separated cell laden layers; distinct
cell layers required separation by multiple acellular layers (Figure 6F). 3D multilayered neurons
were bioprinted in a ring pattern with interconnecting neurites and co-cultures of rat neurons and
astrocytes in a cross (Figure 6G,H); demonstrating that microvalve printing allows patterning of
different cell types in the one 3D construct [194]. This same group used microvalve printing to fabricate
a layered 3D NPCs laden collagen construct with a thrombin crosslinked fibrin gel printed adjacently.
The fibrin gel incorporated soluble vascular endothelial growth factor (VEGF) which was released
gradually over three days [195]. NPCs migrated towards the chemoattractant VEGF-releasing fibrin
gel (Figure 6I,J); increased proliferation and markedly increased branched morphology with neurite
projections was observed in the presence of both VEGF and fibrin, in contrast to either alone [195].
These were the first 3D bioprinted collagen neural cultures, given the promising results of functional
neurons and neural network formation in 3D bulk collagen models [20,58,118] further development
and electrophysiological assessment of this method is warranted. This method of localising growth
factors could be combined with 3D bioprinting to recapitulate the morphogen gradients that drive
organogenesis in vivo [155]. Application of this method with droplets in the picolitre range to increase
the resolution could increase the precision of cell placement, perhaps via inkjet printing.
Like microvalve printing, microfluidic printing relies on pressure to control the flow rate; however,
the bioink is crosslinked prior to deposition at a triton shaped junction where the crosslinking channel,
buffer channel, and bioink channel meet (Figure 5B). Crosslinking takes place rapidly and the crosslinked
fibres are ejected prior to deposition, cells are protected from shear stress due to the formation of a
protective sheath around cells as crosslinking occurs from both sides [196]. De la Vega et al. (2018) used
a microfluidic bioprinting method to print NPC cells with a resolution of 176 µm in a 3D cylindrical
fibrin scaffold for spinal cord repair [196]. Extensive neurite extension and network formation were
visible at 30 days (Figure 6K), by then the printed structure was degraded, yet the cells maintained the
3D shape demonstrating that this method promotes cells to excrete their own ECM [196] (Figure 6L).
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UV laser writing (Figure 5B) was used to 3D bioprint mouse NPCs in GelMA or a nano bioink
consisting of electrically conductive graphene nanoplatelets combined with GelMA (G-GelMA) [197].
NPCs differentiated into mature neurons with limited neurite extension, likely due to the stiffness of the
printed gel, which was ~30 kPa (Gel-MA only). Neurite length was slightly improved in the G-GelMA
compared to GelMA alone, possibly due to the conductive properties of the graphene or perhaps the
addition of transparency reducing graphene resulted in a softer gel with less photo crosslinking [197].
The conductivity and effect of electrical stimulation on bioprinted NPCs should be explored further.
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Figure 5. Methods of bioprinting neurons. (A) Nozzle-based methods: Inkjet and microvalve printing
deposit drops on demand and are more appropriate for soft viscous materials. Microfluidic printing
also uses soft viscous materials but deposits a filament as crosslinking occurs prior to deposition.
Extrusion printing deposits a continuous filament and requires higher viscosity materials, image
adapted from [174,196]. (B) Nozzle free methods include bioacoustic levitational assembly and UV
laser writing [193]. Images reproduced with permission from [174,193,196].
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Figure 6. Inkjet and other bioprinting techniques: (A) Thermally inkjet printed rat hippocampal 
neurons onto collagen sheet [189], scale bar 500 µm. (B) A rat cortical neuron 13 days after being 
thermally inkjet printed [189], scale bar 30 µm. (C) Close up image with arrow showing neuron in 
piezoelectric induced jet [192]. (D) Printed neurons at seven days after piezoelectric printing [191], 
scale bar 100 µm. (E) Piezoelectric printed neurons had initially higher neurite formation compared 
to non-printed controls, which stabilized by day seven [191]. (F) Schematic explaining the rationale 
used to microvalve print hippocampal neurons and astrocytes in (G,H), scale bar in (G) 500 µm, inset 
50 µm and (H) each grid is 500 µm by 500 µm [194]. Neurons migrate and differentiate toward 
vascular endothelial growth factor (VEGF) releasing fibrin gels marked by * in (I,J) [195], scale bar 
200 µm. (K) Microfluidic printed NPCs differentiate into glial (GFAP+ green) and neural (β-Tubulin 
III+ red) lineages, scale bar 50 µm [196]. (L) Microfluidic bioprinted cylinder with diameter of 6693.0 
µm [196]. Live (green) and dead NPCs (red) at (M) day zero and (N) seven days after bioacoustic 
levitation (BAL), scale bar 250 µm [193]. (O) One week after BAL NPCs differentiated into neurons in 
3D layers (β-Tubulin III+ red), progenitor cells (Nestin+ green) [193]. Images reproduced with 
permission from [189,191–196]. 
5.3.4. 3D Bioprinting Summary 
Piezoelectric inkjet bioprinting has given the highest resolution in printing neural cultures 25 ± 
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neurons onto collagen sheet [189], scale bar 500 µm. (B) A rat cortical neuron 13 days after being
thermally inkjet printed [189], scale bar 30 µm. (C) Close up image with arrow showing neuron in
piezoelectric induced jet [192]. (D) Printed neurons at seven days after piezoelectric printing [191],
scale bar 100 µm. (E) Piezoelectric printed neurons had initially higher neurite formation compared
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5.3.4. 3D Bioprinting Sum ary
Piezoel ctric inkjet bio has given the highest resolut on i printing ne ral cultures
25 ± 5 µm [ 91] with igh cell viability; however cells were simply printed into wells of a culture
plate. Cell sedimentation in the printhead reduces the number of printed cells [192]; which can be
reduced to increase print time by flushing the printhead and tubing with trypsin [191]. Interestingly the
number of neurites formed was initially increased in printed samples perhaps due to the piezoelectric
effect stimulating neural differentiation [87,191]. The electrophysiological behaviour of neurons after
piezoelectric printing has not been explored; thermally inject printed neurons have been observed to
have similar electrophysiological properties to damaged neurons [190,198], although other studies have
found no difference compared to non-printed cells [118] (Table 2). Insofar inkjet printing has been used
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to pattern neurons in 2D [118,188,190–192], the only 3D construct was five layers of fibrin hydrogel
sheets patterned with rat hippocampal and cortical neurons [118]. The low viscosity of bioinks used in
inkjet printing impedes construction in the z direction, which could possibly be overcome by printing
within a support structure [124]. Microvalve printing is also a droplet based technique using larger
droplet volumes and has been used to create 3D collagen based constructs with 3D neural network
formation within discrete layers, co-culture cell patterning and incorporated growth factor impregnated
regions [194,195,199]. Microvalve printing has been demonstrated to be amenable to printing 3D
constructs with different hydrogel compositions in different regions; VEGF releasing fibrin crosslinked
via enzymatic action of thrombin, and pH-based crosslinking of collagen. Neural migration towards
the VEGF illustrated that spatially controlled chemoattractant regions incorporated into 3D designs can
be used to further control neural placement and subsequent behaviour via bioprinting [195]. Although
3D, these were not free-standing structures and the spatial control was limited to simple patterns
within layers. Microfluidic bioprinting where the crosslinking occurs prior to droplet deposition
resulting in continuous filament deposition, is more akin to extrusion printing than other droplet based
techniques [196]. Microfluidic bioprinted fibrin 3D cylinders supported NPCs differentiation into
neurons and astrocytes with neurite extension and network formation. After 30 days cellular ECM
production was sufficient to maintain the 3D shape even after the scaffold degraded.
The most spatially defined 3D neural models have been fabricated via extrusion printing, typically
as lattice structures [182–184,200]. Insofar extrusion bioprinting of neural cells in 3D has been limited
to bioprinting the one cell type throughout the construct [182–184,200] (Table 2). Gu et al. differentiated
iPSCs into neurons, astrocytes and oligodendrocytes; however, the cell types were not spatially defined
within the structure [182]. Joung et al. (2018) patterned bioprinted OPCs and NPCs within 3D printed
channel support structures, although there was extensive axon propagation within the channel this
was really 2D patterning within a 3D printed structure. The mechanical characteristics of the bioink
itself were not defined, the excellent neurite extension and functional network formation suggest
the bioink was very viscous; hence why a support structure was used [185]. If a sacrificial scaffold
was used in place of a permanent scaffold perhaps networks could form between channels over time.
Gu et al. (2017) developed the longest living 3D bioprinted neural construct at 40 days. Neurite
extension was somewhat limited because of the stiffness of the mechanical environment [182]; however
synaptogenesis did occur and functionally mature neurons were established. Two neurons showed
synchronous calcium spiking behaviour which suggests they responded in tandem; however to
demonstrate network functionality multiple synchronous responses are required [58,104]. The only 3D
bioprinted neural constructs with demonstrated functionality have been extrusion printed [182–185];
although functionality was inferred from functional recovery in a zebrafish model or calcium flux
assays (Table 2). Electrophysiological assessments are yet to confirm functional neurons and neural
networks of 3D bioprinted constructs. Extrusion based methods of 3D bioprinting are limited to
viscous self-supporting bioinks, which do not mimic the mechanical properties of the native brain.
However, by employing support structures or cryogenic methods this limitation could be overcome.
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Table 2. Overview of different methods used to print neural cells.
Print Type Cell Type Bioink Cell Morphology Cell Viability MechanicalProperties Functionally Active Ref





74 ± 2% NA NA [186]
Extrusion Murine NPCs PCL diol & poly (D,L-lactide) diol
Globular, no
dendrite extension proliferation 680 Pa (E)
Yes (zebra fish brain
injury model) 1 [184]
Extrusion Human NPCs alginate, agarose,carboxymethyl-chitosan.
Limited dendrite




flux assay 2 [182]
Extrusion iPSCs “ “ Not reported “ Yes, calcium flux assay 2 [183]
Extrusion 3 Schwann cells
Composite of alginate,




(day 0–15) (E) NA [145]
Extrusion 3 Schwann cells
Composite of fibrin, HA
and Factor XIII
Bipolar, aligned
with strands 98% NA NA [201]




inc. 6.7 kPa (G’) NA [200]
Extrusion sNPC and OPCs 50% Matrigel Axon propagation >75% (day 4) ~55 kPa (E) Yes, calcium flux assay 2 [185]
Thermal




inkjet Rat neurons Liquid media NA NA
2.92 MPa
(substrate) (E) NA [189]
Thermal
Inkjet Rat retinal ganglion cells
Liquid media containing
BDNF & CNGF Neurite extension NS w.r.t. controls NA Yes, patch clamp [190]
Peizo inkjet Rat glial, retinalganglion cells
2D Liquid media








Neurite extension 86–96%, 82–92%,89–92% NA NA [191]
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Table 2. Cont.




(from human ESC) Fibrin gel
Some neurite
extension ‘majority’ 474 Pa (G’) NA [193]
Microvalve Rat embryonic neurons Layered collagen (0.2%) NA 78.6% NA NA [199]




3D network 78.6%, 78.7% NA NA [194]




Neurite extension 92.89 ± 2.32% NA NA [195]
Microfludic iPSC derived NPCs Fibrin, chitosan, alginate Neurite extension,3D networks >81% NA NA [196]
Direct laser
writing Chick spinal cord cells Media
some neurite
extension Not quantified NA NA [202]
Direct laser
writing hiPSCs
15% hyaluronic acid in






neurite extension Not quantified 30 kPa (GelMA)(EC)
NA [197]
NA: Not assessed; EC = compressive modulus; E = Elastic modulus; G’ = storage modulus. 1 Coiling rate restored to 87% of uninjured control, hatching rate restored to 67% of uninjured
control. 2 Functionality is inferred in calcium flux assay. 3 Technically a seeded scaffold, however scaffold was bioprinted with Schwann cells.
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6. Conclusions and Outlook
Patient specific disease modelling of neural disorders is feasible with iPSCs directed differentiation
into neural tissue. Creation of a neural disease model that accurately mimics brain tissue is a difficult
task due to the highly complex tissue microarchitecture of the brain. Brain tissue is heterogeneous
regarding cell populations and mechanical properties, and very soft. Brain organoids have been
developed but results have had poor reproducibility, limiting their application in disease modelling.
Organoids are limited in size and develop a necrotic core if grown too large due to lack of vascularization.
3D neural models require biomaterials that mimic the mechanical properties of the brain and
support the development of functional neural networks. Hydrogels mimic the poro-viscoelastic
properties of brain tissue and have been demonstrated to support neural growth. Functionally active
neural networks in 3D have been established in bulk gels of low concentration, and therefore soft,
hydrogels of crosslinked collagen, hyaluronic acid and alginate. Bulk gels are simplistic due to
the random cell distribution and cell settling effects, the small pore size also limits mass transport
throughout the gel restricting the size of the model. 3D scaffolds introduce macropores to facilitate mass
transport, 3D printed scaffolds have specifically designed pores or channels, in a highly reproducible
automated manner. Cells are seeded onto scaffolds, and often have poor infiltration of the scaffold.
Cells grow along the surfaces of the scaffold resulting in unnatural constraints affecting morphology
and network disconnection between scaffold areas. 3D bioprinting of cells within the scaffold structure
is a way of overcoming these limitations, while also allowing precise cell patterning.
3D bioprinting of neural models has been restricted by the constraints of developing a bioink that
is soft enough to allow functional network formation and synaptogenesis, yet printable and capable
of maintaining a 3D shape. These conflicting requirements present technical challenges, which may
be overcome by using sacrificial support scaffolding, sacrificial baths or novel crosslinking methods.
Most neural bioprinting studies have focused on cell survival post printing, developing bioinks and
demonstrating neural differentiation in printed constructs. Demonstrating established functional
networks in bioprinted 3D in a reproducible manner is the first milestone to be achieved. The notion
of using bioprinting to specifically arrange cells to replicate heterogeneous cell distribution within
the brain has only been explored minimally with prototype models of alternating or criss-cross cell
patterns, and only with two different cell types. Patterning of multiple cell types including different
glial populations with neural cells is necessary to mirror the varying cell populations within different
brain regions. In the context of disease modelling, iPSCs could be used to grow patient specific
organoids that spontaneously develop distinct brain regions. Cells from each brain region could be
harvested and encapsulated in a suitable bioink for patterning via 3D bioprinting in a reproducible
manner. An alternative method would be to incorporate differentiation cues within the bioink to
develop spatially directed differentiation in a bioprinted organoid approach. Durotactic and haptotactic
cues combined with growth factor gradients could further guide cell migration and neurite extension
to achieve complexity in designed tissue microarchitecture.
Vascularized neural models have not yet been developed. Incorporation of channels to allow mass
transport of waste, nutrients, and oxygen will allow the survival of larger neural models. Dynamic
flow as used in microfluidic devices will further recapitulate the in vivo microenviroment, in place of
vasculature. For disease modelling replication of the blood brain barrier is important to determine
whether prospective treatments will reach the target tissue at an effective concentration, if they are
effective at all.
3D bioprinting of neural models is still in the early stages of development and offers great potential
for exquisite spatial bioink patterning to recapitulate the microarchitecture of brain tissue. Although
3D bioprinted neural disease models have not yet been developed, the potential advantages over
animal models include species and patient specific disease modelling. First, neural models must be
bioprinted with demonstrated functionally active neural networks; only then can bioprinted neural
disease models be compared to animal disease models. The technology to create 3D models of brain
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tissue by bioprinting neurons is still in its infancy, but holds great promise as a new tool for studying
the brain.
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